Matthew Herder

matthewherder.jpg

External Website:

Matthew Herder Dalhousie University Profile

Research Interests

Professor Herder’s research interests cluster around biomedical innovation policy, with particular focus on intellectual property law and practices connected to the commercialization of scientific research. As part of a three-year research project funded by the Canadian Institutes of Health Research, Professor Herder (Principal Investigator) and a team of interdisciplinary researchers are currently collecting empirical evidence about the inter-relationships between commercialization laws, policies, and practices and emerging health researchers. The team will use the collected empirical evidence to explore a series of normative questions about the ongoing commercialization of academic science.

Selected Publications

  • Matthew Herder "What Is the Purpose of the Orphan Drug Act?" (2017) PLoS Med 14(1): e1002191. doi:10.1371/journal.pmed.1002191

  • Matthew Herder “Denaturalizing transparency in drug regulation” 2015 82 McGill Journal of Law and Health S57-S144. 

  • Matthew Herder “Toward a jurisprudence of drug regulation” 2014 422 Journal of Law and Medical Ethics 244–62.

  • Matthew Herder, Elaine Gibson, Janice Graham, Joel Lexchin and Barbara Mintzes “Regulating prescription drugs for patient safety: does Bill C-17 go far enough?” 2014 13:1868 Canadian Medical Association Journal E287–292.

Guest UserVaccinology